Gerrit Klaerner is the founder of Tricida. Tricida has raised $153M in total funding. Latest round: Series D. Based in South San Francisco, CA, USA.
Gerrit Klaerner is the CEO, President, and Board Member of Tricida, a biopharmaceutical company specializing in therapies for renal disease. He is also known for co-founding Ilypsa, which was acquired by Amgen for $420 million, and founding Relypsa, which went public in 2013.
Full founder directory · Investor directory · Company funding database · Fundraising library